INTRODUCTION
============

The prevalence of obesity continues to rise and presents as a major public health concern in Thailand. Essentially, the prevalence of obesity in the 18--24 age group has been doubled for over 10 years ([@b1-jer-15-1-114]). Obesity rises the risks of cardiovascular diseases (CVD) and all-cause of mortality (Jensen et al., 2014). Obesity is also associated with dysregulation of cardiac autonomic function ([@b23-jer-15-1-114]). It has been reported that autonomic dysregulation is an important mediator in the development of CVD risks in obese individuals ([@b23-jer-15-1-114]; [@b35-jer-15-1-114]). Assessment of heart rate variability (HRV) has been recognized as a noninvasive method for assessing cardiac autonomic modulation ([@b39-jer-15-1-114]). Reduced HRV has been associated with higher weight and adiposity ([@b15-jer-15-1-114]; [@b40-jer-15-1-114]). On the other hand, weight reduction via exercise training and/or calorie restriction in obese subjects has been suggested to improve vagal activity ([@b10-jer-15-1-114]; [@b18-jer-15-1-114]; [@b40-jer-15-1-114]). The increase in vagal activity in response to weight loss program may consistently contribute to reduce the risk of cardiovascular morbidity and of sudden cardiac death ([@b10-jer-15-1-114]; [@b15-jer-15-1-114]; [@b18-jer-15-1-114]). However, little is known regarding how exercise-induced body composition changes HRV.

Many have reported that exercise training can alter parasympathetic activity ([@b10-jer-15-1-114]; [@b16-jer-15-1-114]; [@b15-jer-15-1-114]; [@b18-jer-15-1-114]; [@b21-jer-15-1-114]; [@b22-jer-15-1-114]; [@b26-jer-15-1-114]; [@b38-jer-15-1-114]; [@b40-jer-15-1-114]). In contrast, some researches have not shown such effect ([@b5-jer-15-1-114]; [@b9-jer-15-1-114]). The influence of exercise-induced HRV changes is controversial probably due to different exercise training programs and measures of HRV. In addition, most studies are cross sectional and have been conducted on children and adolescents ([@b14-jer-15-1-114]; [@b15-jer-15-1-114]; [@b24-jer-15-1-114]; [@b26-jer-15-1-114]) or obese individuals with chronic diseases ([@b28-jer-15-1-114]; [@b36-jer-15-1-114]). There has been very little research reported on the exercise-induced body composition and aerobic fitness changes HRV ([@b18-jer-15-1-114]; [@b40-jer-15-1-114]), particularly in obese sedentary young adults. There is also a lack of data in males ([@b18-jer-15-1-114]). Therefore, this study attempted to clarify the casual link between the changes in body composition as well as in aerobic fitness and the alterations in cardiac autonomic modulation after a 12-week exercise training. Understanding how exercise-induced body composition and aerobic fitness alters HRV may lead to insights into the risks of CVD and a mean to predict the exercise adaptation in obese sedentary young adults.

MATERIALS AND METHODS
=====================

Subjects and study design
-------------------------

The randomized controlled trial conduced, for which 42 obese men aged 19 to 22 years with body mass index (BMI) ≥25 kg/m^2^ and percentage of body fat (%BF)\>24% ([@b3-jer-15-1-114]), were recruited. Subjects were no regular physical exercise in the last 6 months. Subjects were excluded if they had any clinical sign of CVD, neurological, musculoskeletal limitations to exercise or other overt chronic diseases, or current medication use. Subjects completed a Physical Activity Readiness Questionnaire (PAR-Q) before participating in the study. Subjects were informed of potential risks and the procedure of the study before they signed a written informed consent form. The study protocol was approved by the Kasetsart University Research Ethics Committee (COA61/033) and was conducted according to Declaration of Helsinki.

After the initial evaluation, the 20 eligible obese subjects (age, 20.5±1.2 years; BMI, 31.4±5.2 kg/m^2^; %BF, 30.0%±6.5%) were randomly assigned (1:1) to the exercise (EG, n=10) or control (CG, n=10) group, which were group-matched by age, BMI, and aerobic fitness. The EG group underwent a 12-week combined exercise training program with 4×60-min supervised sessions per week and was asked to maintain habitual diet throughout the study. The CG group did not participate in any weight control programs and was asked to maintain habitual diet and physical activity levels during the study. Measurements were performed in each subject at baseline and 1 week after the last exercise session. Anthropometrics and body composition, peak oxygen consumption (VO~2peak~), and resting HRV were measured at the same time of the day for each subject. Prior to test, subjects were asked to abstain from consumption of alcohol or caffeine-containing beverages for 24 hr. Smoking was also not allowed for at least 4 hr. To ensure consistent baseline activity levels, they were also instructed to avoid intense and/or prolonged exercise for 2 days.

Exercise intervention
---------------------

The EG subjects participated in a 4×60-min sessions/wk of combined exercise program for 12 weeks and was assigned to increase energy expenditure by 452±48.1 kcal/session or 1,825±112.4 kcal/week ([@b32-jer-15-1-114]). Training sessions consisted of 2×30-min sessions/wk with continuous moderate-intensity aerobic exercise (fast walking, jogging, ball games, or swimming) at an intensity between 50% to 70% of individual maximum heart rate (HRmax) and 10×1-min high-intensity interval training for 2 sessions/wk at an intensity between 80% to 90% of HRmax and interspersed with 2 min of recovery, followed by 20 min of strengthening exercises and 10 min of stretching and cool-down. The strengthening exercises were consisted of 2 to 3 series of 10 to 15 repetitions of the arms, legs, and trunk. The strengthening period was determined by the subject's body weight. HR was monitored continuously during each training session using a HR monitor (Forerunner 220, Garmin Ltd., Schaffhausen, Switzerland) and work rate was adjusted to maintain target HR. The training sessions were carefully supervised by experienced trainers. In addition, besides the supervised training sessions, the EG subjects received a recommendation to undergo unsupervised physical activity (by walking 30 min every day). The frequency and duration of unsupervised activities were assessed by a weekly recall questionnaire. The CG subjects did not participate in any intervention and was asked to maintain their habitual diet and physical activity levels throughout the study.

Anthropometrics and body composition measurements
-------------------------------------------------

Body mass and body composition, including %BF, fat mass (FM), and fat free mass (FFM), were measured using a bioimpedance analysis device (Inbody 720, Biospace Inc., Seoul, Korea) with light clothing and without shoes. Height was measured without shoes using a standard stadiometer (Health o Meter Professional, Sunbeam Products Inc., Boca Raton, FL, USA). The BMI was calculated as body mass divided by height squared (kg/m^2^). Waist circumference (W) was measured form midway between the lower rib margin and the iliac crest at the end of inspiration, using a flexible and inextensible measuring tape (Hoechstmass Balzer GmbH, Sulzbach, Hessen, Germany). Hip circumference (H) was also measured at the level of trochanter major and the waist-to-hip circumferences (W/H) ratio was calculated.

VO~2peak~ measurement
---------------------

The VO~2peak~ was measured with an incremental exercise test on an electromagnetically braked cycle ergometer (VIAsprint 150 P, Ergoline GmbH, Bitz, Germany). Briefly, the test was started at a 5-min seated rest on the cycle ergometer, followed by 3 min of baseline unloaded cycling. The incremental protocol was initiated with a work rate of 50 W, and the work rate was increased by 25 W every 2 min. The subjects were encouraged to maintain the fixed pedaling frequency at 50 to 60 rev/min until volitional exhaustion, after which the subjects completed an unloaded recovery period of 3 min. Expired gas samples were collected on a breath-by-breath basis using a portable metabolic device (JAEGER Oxycon Mobile, CareFusion, Hoechberg, Germany), which was calibrated before each test using a 3-L syringe and known concentrations of oxygen (15% O~2~) and carbon dioxide (5% CO~2~). Oxygen consumption (VO~2~), carbon dioxide production (VCO~2~), and HR were continuously recorded and analyzed throughout the test. Arterial O~2~ saturation was continuously monitored using a fingertip pulse oximeter (OLV-3100K, Nihon Kohden, Tokyo, Japan). Rating of perceived exertion was obtained using the Borg scale (6--20) at the end of each work rate. Blood pressure (BP) was recorded using an automatic sphygmomanometer (Tango M2, SunTech Medical Inc., Morrisville, NC, USA) in the last 30 sec of each workload. The VO~2peak~ was defined as the highest 30-sec average value of VO~2~. The VO~2peak~ was achieved when at least three of the following four criteria were met: (a) a plateau in VO~2~ despite an increasing work load, (b) a respiratory exchange ratio \>1.1, (c) a HR within 10/min of HRmax, and (d) volitional exhaustion ([@b17-jer-15-1-114]).

HRV recordings and analysis
---------------------------

The RR intervals were recorded using a 5-min electrocardiogram (ECG) recording (eMotion Faros device, Mega Electronics, Kuopio, Finland) in lying position. The ECG recording was collected online at a sampling rate of 1,000 Hz, in real time, and stored on a computer. The ECG recording took place at a fixed time in the morning (between 8:00 a.m. and 10:00 a.m.) to avoid possible circadian influences on autonomic function. Prior to the recording, subjects rested comfortably supine for at least 20 min in a quiet air-conditioned room with a room humidity and temperature of 67%±1.8% and 25°C±1.1°C, respectively. The respiratory rate, determined by visual inspection of chest movement, was within the normal range (12--20/min).

The RR intervals were analyzed via a software program using the recommendations of the Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology ([@b39-jer-15-1-114]). Time- and frequency-domain parameters together with the Poincaré plot or nonlinear components of HRV were calculated. The time-domain parameters consisted of mean RR intervals, standard deviation of all normal RR intervals (SDNN) and squared differences between adjacent normal NN intervals (RMSSD). The mean RR intervals and the SDNN provided information on sympathetic and parasympathetic cardiac modulation, and the RMSSD subsequently provided information on parasympathetic cardiac modulation. The frequency-domain parameters consisted of low frequency power (LF power: 0.04--0.15 Hz) and high-frequency power (HF power: 0.15--0.4 Hz) and the low-frequency/high-frequency (LF/HF) ratio. The LF power indicated sympathetic and vagal modulations simultaneously, the HF power indicated cardiac vagal modulation, and the LF/HF ratio indicated cardiac sympathetic--vagal balance (Ca\*9/Poincaré plot is a method to illustrate non-linear HRV components. Poincaré parameters, SD1 (Poincaré plot standard deviation perpendicular the line of identity) and SD2 (Poincaré plot standard deviation along the line of identity), were analyzed quantitatively by calculating the standard deviations from the RR interval data. The SD1 related to the fast beat-to-beat variability, while the SD2 described the longer-term variability. The SD1/SD2 ratio reflected non-linear components of HRV ([@b31-jer-15-1-114]; [@b41-jer-15-1-114]).

Statistical analysis
--------------------

All data are presented as mean±standard devaiton. Normality of data distribution was assessed using the Shapiro--Wilk normality tests. HRV variables with skewed distribution were log-transformed using the natural logarithm (ln). A paired *t*-test was used for the within-group comparisons. The difference between groups was compared by analysis of covariance, with adjustment for baseline values. Correlations among changes (Δ; 12-week value -- baseline value) of HRV variables and adiposity measures, and aerobic fitness were performed using Pearson correlation. Stepwise linear regression analysis was also used to predict the variation in each of HRV indexes using the adiposity measures and the aerobic fitness as independent variables. Statistical analyses were performed using IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA). Significant differences were defined as *P*\<0.05.

RESULTS
=======

All subjects completed the 12-week combined exercise program. According to BMI (The Asian-Pacific criteria), 45% of subjects were classified as obese I (25 kg/m^2^\<BMI\<30 kg/m^2^) and 55% as obese II (BMI\>30 kg/m^2^). Forty percent of subjects had waist circumference over 100 cm and 60% had waist circumference between 90 and 100 cm. The mean visceral fat area was 117±48.7 cm^2^. None of the subjects were current smokers. No baseline differences between groups were observed for age, body composition, BP, aerobic fitness, HRV, habitual dietary intake, physical activity levels, or clinical conditions.

Effects of combined exercise training
-------------------------------------

Body mass (*P*\<0.05), BMI (*P*\<0.01), FM (*P*\<0.01), W (*P*\< 0.01), H (*P*\<0.01), and W/H ratio (*P*\<0.01) were significantly reduced in the EG group following the 12-week combined exercise training as compared to baseline levels. Meanwhile, there were no significant differences in any anthropometry or body composition variables in the CG group as compared to baseline levels. In the EG group, the mean reduction in body mass (*P*\<0.01), BMI (*P*\<0.01), FM (*P*\<0.05), W (*P*\<0.01), H (*P*\<0.05), and W/H ratio (*P*\<0.05) following the 12-week combined exercise training were significantly different from the CG group. The absolute (*P*\< 0.01) and relative VO~2peak~ (*P*\<0.01) following the 12-week combined exercise training increased significantly in the EG group compared to baseline values. Meanwhile, there was no significant difference in VO~2peak~ in the CG group compared to baseline values ([Table 1](#t1-jer-15-1-114){ref-type="table"}). In the EG group, the mean improvements in absolute (*P*\<0.01) and relative VO~2peak~ (*P*\<0.01) following the 12-week combined exercise training were significantly different from the CG group ([Table 2](#t2-jer-15-1-114){ref-type="table"}).

The HRV variables following exercise training are presented in [Table 1](#t1-jer-15-1-114){ref-type="table"}. Mean RR intervals (*P*\<0.05) and normalized values of HF (*P*\<0.05) following the 12-week combined exercise training increased significantly, while resting HR (*P*\<0.05), LF (ln msec^2^) (*P*\<0.01), LF/HF ratio (*P*\<0.05), and SD2 (*P*\<0.01) following the 12-week combined exercise training was significantly reduced in the EG group compared to baseline values. Meanwhile, there was no significant difference found in any of the HRV variables in the CG group compared to baseline values. In the EG group, the increase in mean RR intervals (*P*\<0.05) and normalized HF (*P*\< 0.05) and the reduction in resting HR (*P*\<0.05) and LF/HF ratio (*P*\<0.05) following the 12-week combined exercise training were significantly different from the CG group ([Table 1](#t1-jer-15-1-114){ref-type="table"}).

Correlation between the changes in HRV and the changes in adiposity indices and aerobic fitness over the training period
------------------------------------------------------------------------------------------------------------------------

The correlation coefficients (*r*) for changes between HRV variables and adiposity indices and aerobic fitness are presented in [Table 3](#t3-jer-15-1-114){ref-type="table"}. Pearson correlation between the changes in adiposity and HRV changes showed significant positive correlation of W changes with Δ pNN50 (*r*=0.495, *P*\<0.05) ([Fig. 1A](#f1-jer-15-1-114){ref-type="fig"}), and negative correlation of W/H ratio (*r*=−0.450, *P*\<0.05) ([Fig. 1B](#f1-jer-15-1-114){ref-type="fig"}) and FM changes (*r*= −0.502, *P*\<0.05) with Δ mean RR intervals (ln msec) ([Fig. 1C](#f1-jer-15-1-114){ref-type="fig"}). Significant positive correlations were observed between changes of VO~2peak~ and Δ pNN50 (*r*=0.471, *P*\<0.05) ([Fig. 1D](#f1-jer-15-1-114){ref-type="fig"}), and Δ HFnu (*r*=0.425, *P*\<0.05), and Δ SD1/SD2 ratio (*r*=0.570, *P*\<0.01) ([Fig. 1E](#f1-jer-15-1-114){ref-type="fig"}). Meanwhile, the changes of VO~2peak~ and Δ LF/HF ratio (*r*=−0.470, *P*\<0.05) ([Fig. 1F](#f1-jer-15-1-114){ref-type="fig"}) showed significant negative correlation ([Table 3](#t3-jer-15-1-114){ref-type="table"}).

Subjects with greater individual changes in vagal-related HRV variables had more reduction in central obesity, W and W/H ratio, and a greater increase in VO~2peak~ over the training period ([Fig. 1](#f1-jer-15-1-114){ref-type="fig"}). The results of the multiple stepwise regression analysis revealed that only the changes in SD1/SD2 ratio explained a significant proportion of the variance in the relative VO~2peak~ changes (*R*^2^=0.324, *P*\<0.01) ([Table 4](#t4-jer-15-1-114){ref-type="table"}).

DISCUSSION
==========

Our results indicate that vagal activity improves with fat loss and increased aerobic fitness after the exercise training in obese sedentary young men. Changes of the vagal-related HRV variables were significantly related to fat loss. Moreover, the subjects with a greater sympathovagal balance had greater improvement in the aerobic fitness (relative VO~2peak~). These finding suggest that the alteration in resting HRV, especially the SD1/SD2 ratio is a possible predictor for adaptations to exercise training in obese sedentary young men.

Obesity is associated with dysregulation of cardiac autonomic function and rises the risks of CVD. The cardiac autonomic dysfunction has been attributed to excess fat and weight gain ([@b35-jer-15-1-114]). Our findings indicate that the higher reduction in FM and central obesity (measured by W and W/H ratio), the greater alteration of vagal-related HRV variables (mean RR intervals and pNN50). Our study confirms the results of previous studies in which cardiac parasympathetic activity increased with fat loss after exercise training ([@b40-jer-15-1-114]). It was difficult to compare our results with the previous study because our subjects were all men, whereas the other analyzed men and women together ([@b40-jer-15-1-114]). It has been suggested that gender influences HRV; healthy men at age \<30 years have been reported to have greater HRV variables than women, and age also affects cardiac autonomic control of HR ([@b42-jer-15-1-114]). A previous study ([@b33-jer-15-1-114]) reported that the vagal activity related to a large weight loss by an average of 9.5% (8.7 kg). However, in our present study, the vagal-related HRV variables correlated to the reduction in FM and central obesity instead of the weight loss (2.3% or 2.2 kg). The interindividual differences in mean RR intervals with fat loss (6.6% or 2 kg) were observed in this study. Indeed, the changes in central obesity (measured by W and W/H ratio) correlated with changes in vagal-related HRV variables (mean RR intervals and pNN50). The more central fat loss, the more increased vagal activity. Obese individuals with higher central fat were sympathovagal imbalance compared to those with lower central fat ([@b37-jer-15-1-114]). Another study confirmed the improvements in vagal-related HRV variables elicited by exercise training correlated with altered trunk fat percentage and/or W in overweight and obese adults ([@b40-jer-15-1-114]). Thus, the regional fat distribution might contribute to the individual differences in HRV response ([@b8-jer-15-1-114]). These finding demonstrate that central obesity influences vagal activity after exercise training. Although weight reduction in obese subjects has been suggested to improve parasympathetic activity ([@b20-jer-15-1-114]; [@b33-jer-15-1-114]), such effect was not observed in ([@b25-jer-15-1-114]). Thus, the casual link between weight loss and beneficial alterations in cardiac autonomic function is still unclear. In addition, influence of continuous endurance training with moderate intensity on resting HRV was not observed in obese women without fat loss ([@b11-jer-15-1-114]). Nevertheless, such influence of a progressive-intensity training was observed with fat loss ([@b40-jer-15-1-114]). In our study, an improved vagal-related HRV variables was observed after the exercise training in obese sedentary young men with fat loss. This might demonstrate a correlation between the fat loss due to exercise training and the improved HRV. The vagal-related HRV variables appear to be influenced in individuals with fat loss, especially central fat in our study. However, low R-squared values (*R*^2^=0.252, *P*\<0.05) revealed that reduced FM does not fully explain the improvement in HRV. Alterations of potential contributing factors might be involved, such as insulin resistance ([@b23-jer-15-1-114]), leptin ([@b30-jer-15-1-114]), and inflammation ([@b2-jer-15-1-114]).

Low aerobic fitness and abnormalities of cardiac autonomic modulation are significant contributors to increased CVD risk in obese individuals ([@b13-jer-15-1-114]; [@b27-jer-15-1-114]; [@b29-jer-15-1-114]; [@b44-jer-15-1-114]). Our findings indicate that the 12-week combined exercise training program is able to improve aerobic fitness and to favorably modify sympathovagal balance, with increases in mean RR intervals and normalized HF and decreases in resting HR and the LF/HF ratio. These findings are consistent with previous studies supporting the idea that training improves autonomic function ([@b6-jer-15-1-114]; [@b40-jer-15-1-114]; [@b43-jer-15-1-114]). Interestingly, the reduction in resting HR may explain why we observed significant increases in normalized HF values and a reduction in the LF/HF ratio, as the variables are primarily mediated by RR intervals. It has been suggested that lower resting HR can result from an increase in vagal and a reduction in sympathetic outflow. The adaptations to exercise training appear to affect both branches of the autonomic nervous system (ANS) ([@b7-jer-15-1-114]). Our findings are consistent with the improvement in sympathovagal balance after the exercise training already suggested by the HRV variables (mean RR intervals, HFnu, and LF/HF ratio). The reduction in resting HR possibly contributes to the improvement observed in aerobic fitness ([@b6-jer-15-1-114]; [@b10-jer-15-1-114]). Our results confirm that moderately strong correlations were found between the changes in pNN50, HFnu, LF/HF ratio, and SD1/SD2 ratio versus the increased in aerobic fitness. These associations concur with previous studies which revealed that higher aerobic fitness is associated with a higher vagal cardiac control ([@b7-jer-15-1-114]; [@b12-jer-15-1-114]; [@b26-jer-15-1-114]). Increased parasympathetic and decreased sympathetic outflow to the heart elicited by exercise training is typically considered a factor in cardioprotection ([@b4-jer-15-1-114]). Our findings are supported by the stepwise regression analysis revealing that changes in the SD1/SD2 ratio can predict 32.4% of the variance in the relative VO~2peak~ changes. The SD1/SD2 ratio is the most important predictor of changes in aerobic fitness elicited by exercise training. The SD1 indicates the parasympathetic activity, the SD2 indicates the sympathetic modulation, and the SD1/SD2 ratio indicates the sympathovagal balance ([@b34-jer-15-1-114]). Moreover, the high SD1/SD2 ratio can be used as an indicator of healthy cardiac dynamics ([@b34-jer-15-1-114]). As the SD1/SD2 ratio is proposed to be a good measure of sympathovagal balance, it can be assumed that an increased parasympathetic and a decreased sympathetic outflow to the heart may be related to improved performance.

To our knowledge, this is the first study detailing the effect of exercise training in the ANS response to fat loss and aerobic capacity in obese sedentary young men. Sympathovagal balance elicited by the exercise training correlated with fat loss and aerobic fitness. These findings appeared to support a concept of cardiovascular protection that regular physical activity could reduce mortality and morbidity of CVD. Moreover, our results suggested that resting HRV, especially the SD1/SD2 ratio, might be a predictor of CRF in overweight and obese young men. However, the study had limitations. The number of subjects was small. Furthermore, there were no data in females; neither were sex-related differences in HRV studied.

These findings suggested that obese sedentary young men achieved significant improvements in vagal activity, adiposity indices and aerobic fitness after 12 weeks of the combined exercise training. The improvements in vagal activity elicited by the exercise training program correlated with fat loss in obese sedentary young men. Moreover, the subjects with a greater sympathovagal balance had greater improvement in the aerobic fitness. These finding suggest that the alteration in resting HRV is a possible predictor for adaptations to exercise training in obese sedentary young men.
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###### 

Heart rate variability variables measured at baseline and after 12-week exercise training

  Variable                   CG (n=10)   EG (n=10)               
  -------------------------- ----------- ----------- ----------- -----------------------------------------------------------------------------------------------------
  Resting HR (msec)          67.8±6.1    69.2±7.1    72.1±7.6    66.3±3.7[\*](#tfn3-jer-15-1-114){ref-type="table-fn"},[†](#tfn5-jer-15-1-114){ref-type="table-fn"}
                                                                 
  Mean RR intervals (msec)   6.8±0.1     6.7±0.1     6.7±0.1     6.8±0.1[\*](#tfn3-jer-15-1-114){ref-type="table-fn"},[†](#tfn5-jer-15-1-114){ref-type="table-fn"}
                                                                 
  SDNN (msec)                4.2±0.4     4.1±0.5     4.2±0.3     4.2±0.3
                                                                 
  RMSSD (msec)               3.9±0.9     3.7±0.6     3.9±0.4     3.9±0.3
                                                                 
  pNN50 (%)                  25.7±18.3   27.2±24.0   30.2±16.6   33.7±15.4
                                                                 
  TP (msec^2^)               8.1±0.9     7.8±1.1     8.3±0.5     8.1±7.2
                                                                 
  HF (msec^2^)               6.9±1.1     6.3±1.3     6.7±0.9     6.9±0.1
                                                                 
  HF (nu)                    30.6±12.3   24.8±11.9   24.6±14.0   33.0±12.6[\*](#tfn3-jer-15-1-114){ref-type="table-fn"},[†](#tfn5-jer-15-1-114){ref-type="table-fn"}
                                                                 
  LF (msec^2^)               7.2±1.0     6.9±1.2     7.3±0.8     6.8±1.4[\*](#tfn3-jer-15-1-114){ref-type="table-fn"}
                                                                 
  LF (nu)                    40.8±16.2   41.2±17.7   39.3±18.2   38.2±14.2
                                                                 
  LF/HF ratio                1.9±2.2     2.6±3.1     2.4±2.1     1.7±1.5[\*\*](#tfn4-jer-15-1-114){ref-type="table-fn"},[†](#tfn5-jer-15-1-114){ref-type="table-fn"}
                                                                 
  SD1                        47.0±30.6   35.6±25.7   38.2±12.0   38.3±13.0
                                                                 
  SD2                        94.0±36.5   85.7±43.3   92.8±21.4   88.1±24.6[\*\*](#tfn4-jer-15-1-114){ref-type="table-fn"}
                                                                 
  SD1/SD2 ratio              0.5±0.2     0.4±0.1     0.4±0.1     0.4±0.1

Values are presented as mean±standard deviation.

CG, control group; EG, exercise group; HR, heart rate; SDNN, standard deviation of normal RR intervals; RMSSD, squared differences between adjacent normal NN intervals; pNN50, percentage difference between adjacent normal RR intervals \>50 msec; TP, total power; HF, high-frequency power; LF, low-frequency power; LF/HF ratio, low-frequency to high-frequency ratio; SD1, Poincaré plot standard deviation perpendicular the line of identity; SD2, Poincaré plot standard deviation along the line of identity.

*P*\<0.05,

*P*\<0.01, significant difference from baseline within group.

*P*\<0.05, significant difference in mean change between groups.

###### 

Adiposity and cardiorespiratory fitness measured at baseline and after 12-week exercise training

  Variable                CG (n=10)    EG (n=10)                 
  ----------------------- ------------ ------------ ------------ ---------------------------------------------------------------------------------------------------------
  Age (yr)                20.7±1.2     \-           20.3±1.3     \-
                                                                 
  Height (cm)             174.6±5.7    \-           174±6.6      \-
                                                                 
  Body mass (kg)          97.8±19.6    97.8±19.6    97.8±19.6    97.8±19.6[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[††](#tfn10-jer-15-1-114){ref-type="table-fn"}
                                                                 
  BMI (kg/m^2^)           31.4±5.3     31.4±5.3     31.4±5.3     31.4±5.3[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[††](#tfn10-jer-15-1-114){ref-type="table-fn"}
                                                                 
  Body fat (%)            29.6±13.4    29.9±13.3    30.5±13.5    28.6±13.5
                                                                 
  Fat mass (kg)           68.7±8.2     69.0±9.0     65.0±8.9     65.0±8.0[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[†](#tfn9-jer-15-1-114){ref-type="table-fn"}
                                                                 
  FFM (kg)                39.3±5.0     39.5±5.6     37.1±5.1     37.3±4.5
                                                                 
  W (cm)                  100.9±15.6   102.3±15.8   100.2±15.2   97.7±14.7[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[††](#tfn10-jer-15-1-114){ref-type="table-fn"}
                                                                 
  H (cm)                  112.7±8.5    112.6±9.5    111.2±10.5   108.1±11.0[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[†](#tfn9-jer-15-1-114){ref-type="table-fn"}
                                                                 
  W/H ratio               0.91±0.04    0.91±0.04    0.91±0.04    0.90±0.04[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[†](#tfn9-jer-15-1-114){ref-type="table-fn"}
                                                                 
  VO~2peak~ (L/min)       2.6±0.4      2.6±0.4      2.5±0.3      2.8±0.3[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[††](#tfn10-jer-15-1-114){ref-type="table-fn"}
                                                                 
  VO~2peak~ (mL/kg/min)   27.1±5.3     27.0±5.4     26.9±5.4     30.5±4.6[\*\*](#tfn8-jer-15-1-114){ref-type="table-fn"},[††](#tfn10-jer-15-1-114){ref-type="table-fn"}

Values are presented as mean±standard deviation.

CG, control group; EG, exercise group; BMI, body mass index; FFM, fat free mass; SMM, skeletal muscle mass; W, waist circumference; H, hip circumference; W/H ratio, waist to hip circumference; VO~2peak~, peak oxygen consumption.

*P*\<0.01, significant difference from baseline within group.

*P*\<0.05,

*P*\<0.01, significant difference in mean change between groups.

###### 

Correlation coefficients (*r*) of changes between adiposity indices and aerobic fitness and heart rate variability variables

  Variable                 ΔRR intervals (msec)                                   ΔSDNN (msec)   ΔRMSSD (msec)   ΔpNN50 (%)                                            ΔTP (msec^2^)   ΔHF (msec^2^)   ΔHF (nu)                                              ΔLF (msec^2^)   ΔLF (nu)   Δ(LF/HF) ratio                                         Δ(SD1/SD2) ratio
  ------------------------ ------------------------------------------------------ -------------- --------------- ----------------------------------------------------- --------------- --------------- ----------------------------------------------------- --------------- ---------- ------------------------------------------------------ -------------------------------------------------------
  ΔBody mass (kg)          −0.411                                                 −0.186         −0.112          0.093                                                 0.033           −0.129          −0.234                                                −0.145          −0.401     −0.024                                                 0.051
  ΔBMI (kg/m^2^)           −0.406                                                 −0.117         −0.092          0.082                                                 0.077           −0.092          −0.259                                                −0.081          −0.286     0.008                                                  0.050
  ΔBody fat (%)            −0.397                                                 −0.078         0.032           0.050                                                 −0.058          −0.137          −0.132                                                −0.151          −0.170     −0.015                                                 0.121
  ΔFat mass (kg)           −0.502[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   −0.071         0.008           0.073                                                 −0.007          −0.134          −0.211                                                −0.138          −0.258     −0.026                                                 0.124
  ΔFFM (kg)                0.085                                                  −0.065         −0.109          0.015                                                 0.080           0.024           −0.056                                                0.050           −0.024     0.064                                                  −0.087
  ΔW (cm)                  −0.113                                                 −0.013         0.059           0.495[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   0.016           −0.202          −0.378                                                −0.185          −0.020     0.213                                                  0.103
  Δ(W/H ratio)             −0.450[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   −0.068         0.028           0.045                                                 −0.029          −0.109          −0.101                                                −0.165          −0.284     −0.066                                                 0.117
  ΔVO~2peak~ (L/min)       0.153                                                  −0.001         0.169           0.360                                                 −0.033          0.240           0.459[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   −0.373          −0.233     −0.444[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   0.500[\*\*](#tfn15-jer-15-1-114){ref-type="table-fn"}
  ΔVO~2peak~ (mL/kg/min)   0.225                                                  0.100          0.270           0.471[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   0.044           0.310           0.425[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   −0.349          −0.212     −0.470[\*](#tfn14-jer-15-1-114){ref-type="table-fn"}   0.570[\*\*](#tfn15-jer-15-1-114){ref-type="table-fn"}

Absolute change (Δ; 12-week value -- baseline value).

BMI, body mass index; FFM, fat free mass; W, waist circumference; W/H ratio, waist to hip circumference; VO~2peak~, peak oxygen consumption; SDNN, standard deviation of normal RR intervals; RMSSD, square root of the mean squared difference between adjacent normal RR intervals; pNN50, percentage difference between adjacent normal RR intervals \>50 msec; TP, total power; HF, high-frequency power; LF, low-frequency power; LF/HF, low-frequency to high-frequency ratio; SD1, Poincaré plot standard deviation perpendicular the line of identity; SD2, Poincaré plot standard deviation along the line of identity.

n=20.

*P*\<0.05.

*P*\<0.01.

###### 

Stepwise liner regression analysis for factors associated with the relative VO~2peak~

                   Changes in VO~2peak~ (mL/kg/min)                                                                                           
  ---------------- ---------------------------------- ------- ------- ------- ------- ------------------------------------------------------- -------------------------------------------------------
  Constant         2.039                              0.516   \-      3.953   0.001   \-                                                      \-
  ΔSD1/SD2 ratio   8.141                              2.769   0.570   2.940   0.009   0.570[\*\*](#tfn17-jer-15-1-114){ref-type="table-fn"}   0.324[\*\*](#tfn17-jer-15-1-114){ref-type="table-fn"}

VO~2peak~, peak oxygen consumption; SD1, Poincaré plot standard deviation perpendicular the line of identity; SD2, Poincaré plot standard deviation along the line of identity; SEM, standard error of the mean.

*P*\<0.01.
